Mammograms Specialist Westlake OH

DCIS is a noninvasive condition in which abnormal cells are found in the lining of a breast duct. It is not cancer, but it may, in some cases, become invasive cancer and spread to other tissues. Because they can’t predict which lesions will become invasive cancer and which will remain contained in the breast duct, doctors usually treat DCIS like cancer.

Steven Robert Savona, MD
950 Clague Rd
Westlake, OH
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Duke Univ Sch Of Med, Durham Nc 27710
Graduation Year: 1978

Data Provided by:
Marwan Massouh
(440) 808-6500
29101 Health Campus Dr
Westlake, OH
Specialty
Internal Medicine, Hematology / Oncology

Data Provided by:
John J Gaughan, MD
(440) 331-8953
4498 W 214th St
Fairview Park, OH
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Laura Kate Gowans, MD
(440) 933-7327
294 Vinewood Dr
Avon Lake, OH
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Wayne State Univ Sch Of Med, Detroit Mi 48201
Graduation Year: 1997

Data Provided by:
Asif Ali Chaudhry, MD
(216) 476-7606
18200 Lorain Ave
Cleveland, OH
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: King Edward Med Coll, Univ Of Punjab, Lahore, Pakistan
Graduation Year: 1964

Data Provided by:
Nizar Jack Bahlis, MD
(305) 243-6301
Westlake, OH
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: St Joseph'S Univ, Fac Of Med, Beirut, Lebanon
Graduation Year: 1995

Data Provided by:
Steven R Savon, MR
(440) 250-2001
960 Clague Rd Ste 1200
Westlake, OH
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Laura M Nadeau, MD
Avon Lake, OH
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Case Western Reserve Univ Sch Of Med, Cleveland Oh 44106
Graduation Year: 1999

Data Provided by:
Hamed Daw
(216) 476-7606
18200 Lorain Ave
Cleveland, OH
Specialty
Hematology / Oncology

Data Provided by:
Vincent J O'Brien
(216) 529-1440
14601 Detroit Ave
Lakewood, OH
Specialty
Internal Medicine, Hematology / Oncology

Data Provided by:
Data Provided by:

Mandatory Mammograms

Provided by: 

By Vonalda M. Utterback, CN

“Time to make breast pancakes,” says one friend of mine, referring to her scheduled mammography screening. And although she may crack jokes about the experience, she’s never once questioned the need for her annual pilgrimage, nor has her physician discussed the risks versus the benefits it entails. After all, if you are a woman aged 40 or beyond, yearly mammograms are simply de rigueur.

When your doctor refers you for a screening, he or she is likely following the guidelines of the two leading national cancer research and information organizations primarily responsible for setting public health policy on cancer screening: The private American Cancer Society (ACS) and the government’s National Cancer Institute (NCI). Both, along with other well-funded, high-profile organizations, such as Susan G. Komen for the Cure, recommend regular mammogram screening of symptom-free women beginning at age 40.

All this official blessing shouldn’t make regular screening mammography sacrosanct, however. In fact, it’s way past time for women to start asking hard questions about the exam’s efficacy and its potential harm, say many women’s health experts, advocates, and researchers. “Screening mammography is clearly a double-edged sword,” explains Lisa Schwartz, MD, co-director of the Veteran’s Administration Outcomes Group in White River Junction, Vermont, and associate professor of medicine at Dartmouth Medical School.

False truths
According to the National Academy of Sciences 2005 publication, Saving Women’s Lives: Strategies for Improving Breast Cancer Detection and Diagnosis, the risk of a false-positive result in a mammogram is about 1 in 10. About three-quarters of the resulting biopsies turn out to be benign, it’s true, but to learn that a woman has to endure the fear that she has breast cancer and bear the cost, discomfort, and risk of additional medical procedures.

“Regular screening will save some lives, but it will cause even more women to be harmed through the unnecessary diagnosis and treatment of cancer that would never have affected their health, were it not for screening,” says Schwartz. She’s referring to false-positives associated with “ductal carcinoma in situ” (DCIS), a result that many experts consider one of the most harmful risks associated with screening mammography.

DCIS is a noninvasive condition in which abnormal cells are found in the lining of a breast duct. It is not cancer, but it may, in some cases, become invasive cancer and spread to other tissues. Because they can’t predict which lesions will become invasive cancer and which will remain contained in the breast duct, doctors usually treat DCIS like cancer. “Most women with DCIS will be advised to undergo invasive treatment of unknown benefit, such as lumpectomy combined with radiation,” reports Schwartz.
Harm from over-diagnosis of invasive cancer also may occur because many malignant cancers grow quite slowly, says Peter C. Gotzsche, MD, r...

Author: Vonalda M. Utterback, CN

Copyright 1999-2009 Natural Solutions: Vibrant Health, Balanced Living/Alternative Medicine/InnoVisi...